Inventor · disambiguated record
Didier Schils
Also filed as: SCHILS DIDIER · SCHILS DIDIER PHILIPPE ROBERT
13 granted patents·4 pending applications·35 citations·filing 2003–2022
88Inventor score
Files withJANSSEN PHARMACEUTICA NV4EPICS THERAPEUTICS3ABBVIE GLOBAL ENTPR LTD2EUROSCREEN SA2OGEDA SA2
Top patents by PatentIndex Score
17 records- 0185US7705148B2Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrileJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Apr 27, 2010·7 cites·9 claims
- 0285US7399856B2Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-2pyrimidinyl]amino]benzonitrileJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Jul 15, 2008·19 cites·12 claims
- 0384US7563922B2Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrileJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Jul 21, 2009·6 cites·6 claims
- 0474US8101752B2Process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino]benzonitrileSCHILS DIDIER PHILIPPE ROBERT·Filed 2006·Granted Jan 24, 2012·2 cites·15 claims
- 0568US11072582B2Substituted pyrrolidines as G-protein coupled receptor 43 agonistsEPICS THERAPEUTICS·Filed 2020·Granted Jul 27, 2021·0 cites·25 claims
- 0668US10781171B2Substituted pyrrolidines as G-protein coupled receptor 43 agonistsEPICS THERAPEUTICS·Filed 2020·Granted Sep 22, 2020·0 cites·1 claims
- 0767US10577318B2Substituted pyrrolidines as G-protein coupled receptor 43 agonistsEPICS THERAPEUTICS·Filed 2019·Granted Mar 3, 2020·0 cites·1 claims
- 0864US9695120B2Substituted pyrrolidines as G-protein coupled receptor 43 agonistsHOVEYDA HAMID R·Filed 2012·Granted Jul 4, 2017·1 cites·36 claims
- 0962US10358416B2Substituted pyrrolidines as G-protein coupled receptor 43 agonistsOGEDA SA·Filed 2018·Granted Jul 23, 2019·0 cites·2 claims
- 1059US10017468B2Substituted pyrrolidines as G-protein coupled receptor 43 agonistsOGEDA SA·Filed 2017·Granted Jul 10, 2018·0 cites·3 claims
- 1156US2022281857A1Prodrug Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE GLOBAL ENTPR LTD·Filed 2022·Application pending·0 cites
- 1255US11345691B2Prodrug modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE GLOBAL ENTPR LTD·Filed 2020·Granted May 31, 2022·0 cites·3 claims
- 1353US8618291B2Process for preparing 4-[(1,6-dihydro-6-OXO-2-pyrimidinyl)amino]benzonitrileSCHILS DIDIER PHILIPPE ROBERT·Filed 2011·Granted Dec 31, 2013·0 cites·17 claims
- 1453US2024124424A1Solid forms of (5s)-cyclopropyl-5-[3-[(3s)-4-(3,5-difluorophenyl)-3-methyl-piperazin-1-yl]-3-oxo-propyl]imidazolidine-2,4-dioneGALAPAGOS NV·Filed 2021·Application pending·0 cites
- 1551US2011230477A1Compounds, pharmaceutical composition and methods for use in treating metabolic disordersEUROSCREEN SA·Filed 2009·Application pending·0 cites
- 1650US2009253918A1Novel intermediate for glyt1 inhibitorJANSSEN PHARMACEUTICA NV·Filed 2007·Application pending·0 cites
- 1744US9770435B2Compounds, pharmaceutical composition and methods for use in treating inflammatory diseasesEUROSCREEN SA·Filed 2014·Granted Sep 26, 2017·0 cites·36 claims
Join the waitlist — get patent alerts
Get an alert when Didier Schils files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →